Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Vipivotide tetraxetan Linker

Copy Product Info
😃Good
Catalog No. T17233Cas No. 1703768-74-4
Alias PSMA-617 Linker

Vipivotide tetraxetan Linker (PSMA-617 Linker) is a noncleavable peptide linker utilized in the synthesis of Vipivotide tetraxetan (PSMA-617), a ligand instrumental in producing 177Lu-PSMA-617. This radioactive molecule is applied in the treatment of prostate cancer[1].

Vipivotide tetraxetan Linker

Vipivotide tetraxetan Linker

Copy Product Info
😃Good
Catalog No. T17233Alias PSMA-617 LinkerCas No. 1703768-74-4
Vipivotide tetraxetan Linker (PSMA-617 Linker) is a noncleavable peptide linker utilized in the synthesis of Vipivotide tetraxetan (PSMA-617), a ligand instrumental in producing 177Lu-PSMA-617. This radioactive molecule is applied in the treatment of prostate cancer[1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$837-10 days7-10 days
10 mg$1147-10 days7-10 days
25 mg$2147-10 days7-10 days
50 mg$3577-10 days7-10 days
100 mg$6437-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Vipivotide tetraxetan Linker (PSMA-617 Linker) is a noncleavable peptide linker utilized in the synthesis of Vipivotide tetraxetan (PSMA-617), a ligand instrumental in producing 177Lu-PSMA-617. This radioactive molecule is applied in the treatment of prostate cancer[1].
SynonymsPSMA-617 Linker
Chemical Properties
Molecular Weight655.74
FormulaC33H45N5O9
Cas No.1703768-74-4
SmilesNCC1CCC(CC1)C(=O)NC(Cc1ccc2ccccc2c1)C(=O)NCCCCC(NC(=O)NC(CCC(O)=O)C(O)=O)C(O)=O
Relative Density.1.303 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 270 mg/mL (411.75 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (5.03 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.5250 mL7.6250 mL15.2499 mL76.2497 mL
5 mM0.3050 mL1.5250 mL3.0500 mL15.2499 mL
10 mM0.1525 mL0.7625 mL1.5250 mL7.6250 mL
20 mM0.0762 mL0.3812 mL0.7625 mL3.8125 mL
50 mM0.0305 mL0.1525 mL0.3050 mL1.5250 mL
100 mM0.0152 mL0.0762 mL0.1525 mL0.7625 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Vipivotide tetraxetan Linker | purchase Vipivotide tetraxetan Linker | Vipivotide tetraxetan Linker cost | order Vipivotide tetraxetan Linker | Vipivotide tetraxetan Linker chemical structure | Vipivotide tetraxetan Linker formula | Vipivotide tetraxetan Linker molecular weight